exRNAdisease

Entry Detail

---



General Information

Database ID: exR0410123 RNA Name: FGD5-AS1 RNA Type: lncRNA Chromosome: chr3 Starnd: - Coordinate: Start Site(bp): 14920347 End Site(bp): 14948424 External Links: ENSG00000225733

Disease Information

Disease Name: Clear Cell Renal Cell Carcinoma Disease Category: Cancers MeSH ID: D002292 Type: Neoplasms/Urogenital Neoplasms Alias: Carcinoma, Renal Cell//Carcinomas, Renal Cell//Renal Cell Carcinomas//Adenocarcinoma, Renal Cell//Adenocarcinomas, Renal Cell//Renal Cell Adenocarcinoma//Renal Cell Adenocarcinomas//Adenocarcinoma Of Kidney//Adenocarcinoma Of Kidneys//Kidney, Adenocarcinoma Of//Kidneys, Adenocarcinoma Of//Renal Cell Cancer//Cancer, Renal Cell//Cancers, Renal Cell//Renal Cell Cancers//Adenocarcinoma, Renal//Adenocarcinomas, Renal//Renal Adenocarcinoma//Renal Adenocarcinomas//Nephroid Carcinoma//Carcinoma, Nephroid//Carcinomas, Nephroid//Nephroid Carcinomas//Renal Cell Carcinoma//Chromophobe Renal Cell Carcinoma//Sarcomatoid Renal Cell Carcinoma//Papillary Renal Cell Carcinoma//Renal Cell Carcinoma, Papillary//Chromophil Renal Cell Carcinoma//Clear Cell Renal Cell Carcinoma//Grawitz Tumor//Tumor, Grawitz//Clear Cell Renal Carcinoma//Carcinoma, Hypernephroid//Carcinomas, Hypernephroid//Hypernephroid Carcinoma//Hypernephroid Carcinomas//Hypernephroma//Hypernephromas//Collecting Duct Carcinoma (Kidney)//Carcinoma, Collecting Duct (Kidney)//Carcinomas, Collecting Duct (Kidney)//Collecting Duct Carcinomas (Kidney)//Collecting Duct Carcinoma of the Kidney//Renal Collecting Duct Carcinoma//Collecting Duct Carcinoma//Carcinoma, Collecting Duct//Carcinomas, Collecting Duct//Collecting Duct Carcinomas

Expression Detail

GEO ID: GSE125442 Description: Urinary exosomal long noncoding RNAs may be novel biomarkers for the diagnosis of clear cell renal cell carcinoma Experimental Design: Cancer vs Control Case Disease Type: Clear Cell Renal Cell Carcinoma Case Disease SubType: NA Case Sample: Clear Cell Renal Cell Carcinoma Control Sample: Healthy Number of Case: 10 Number of Control: 10 Number of Samples: 20

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ACOT7 chr1 6264269 6394391 - ADAM10 chr15 58588809 58749791 - AGAP3 chr7 151085831 151144436 + AGGF1 chr5 77029251 77065234 + miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-3611 chr10 35079609 35079629 - hsa-miR-302c-3p chr4 112648366 112648388 - hsa-miR-421 chrX 74218392 74218414 - hsa-miR-1179 chr15 88608121 88608141 + hsa-miR-20a-5p chr13 91351072 91351094 + hsa-miR-493-5p chr14 100869075 100869096 + hsa-miR-497-5p chr17 7017979 7017999 - hsa-miR-105-5p chrX 152394458 152394480 - hsa-miR-520a-3p chr19 53690933 53690954 + hsa-miR-548o-3p chr20 38516607 38516628 + hsa-miR-196a-5p chr17 48632532 48632553 - hsa-miR-506-3p chrX 147230753 147230773 - hsa-miR-3622b-5p chr8 27701726 27701745 - hsa-miR-3681-5p chr2 12199138 12199159 + hsa-miR-126-5p chr9 136670616 136670636 + hsa-miR-892c-5p chrX 145992796 145992816 - hsa-miR-382-5p chr14 101054316 101054337 + hsa-miR-577 chr4 114656774 114656794 + hsa-miR-670-3p chr11 43559714 43559734 + hsa-miR-512-3p chr19 53666729 53666750 + hsa-miR-33a-5p chr22 41900949 41900969 + hsa-miR-424-5p chrX 134546680 134546701 - hsa-miR-3146 chr7 19705366 19705387 - hsa-miR-888-5p chrX 145994830 145994850 - hsa-miR-520c-3p chr19 53707506 53707527 + hsa-miR-15a-5p chr13 50049167 50049188 - hsa-miR-103a-3p chr5 168560904 168560926 - hsa-miR-520d-5p chr19 53720111 53720130 + hsa-miR-7853-5p chr6 6169380 6169400 - hsa-miR-1323 chr19 53671978 53671999 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC018521.1 chr17 47945424 47981736 + AC092902.2 chr3 125774714 125797953 + Display:

Experiment Detail

GEO ID: GSE125442 Sample Source: Urine Source Fraction: Exosome Platform: GPL21290 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 882 Sample treatment protocol: Exosomes were isolated by ultracentrifugation from 50-ml urine samples. RNA Extract protocol: A MiRNeasy Serum/Plasma Kit (QIAGEN, Valencia, CA, USA) was used to extract RNA from urinary exosome samples in accordance with the manufacturer's protocol. RNA library preparation protocol: Fragmented RNA (the average length was approximately 200 bp) were subjected to first strand and second strand cDNA synthesis following by adaptor ligation and enrichment with a low-cycle according to instructions of NEBNext® Ultra™ RNA Library Prep Kit for Illumina (NEB, USA).

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA